First in Class: YR001 topical ointment, developed by YR Pharma for autoimmune skin diseases, has received approval for clinical trials.

-
Mar 2
The pharmaceutical industry has learned that Hangzhou Yirui Pharmaceutical Technology Co., Ltd. (hereinafter […]
Read Article